TRIS: Contingency Management App for Alcohol Use Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity of Sao Paulo General Hospital

About this trial

Alcohol Use Disorder (AUD) is a major public health concern associated with substantial morbidity, mortality, and impaired social and occupational functioning. Contingency Management (CM) is an evidence-based behavioral intervention that provides incentives contingent on abstinence and has demonstrated effectiveness in the treatment of substance use disorders. This study will evaluate the efficacy of Tratamento Remoto com Incentivos à Sobriedade (TRIS), a Brazilian mobile health application that integrates a smartphone app with a Bluetooth-enabled breathalyzer (BACtrack) to deliver remote CM for AUD. Participants will be randomized to receive either standard outpatient treatment plus TRIS-based CM or standard outpatient treatment with remote alcohol monitoring only. The primary objective is to determine whether TRIS-based CM increases biochemically verified alcohol abstinence compared with standard outpatient treatment alone.

Eligibility criteria

Qualifiers

Able to read and speak Portuguese.

Provide signed informed consent.

Age 18 to 70 years.

Alcohol consumption within the past month.

Disqualifiers

Crack cocaine use within the past 90 days.

Any seizure episode within the past 12 months.

Diagnosis of a psychotic disorder (DSM-5).

Suicide attempt within the past two years.

Trial design

Treatments tested in this trial

  • Remote Contingency Management (CM)
  • Treatment as Usual (TAU)

Treatment groups

130 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Sao Paulo General Hospital

Lead sponsor

University of Sao Paulo

Collaborator

Medical school of the University of São Paulo (FMUSP)

Collaborator